Drug-associated renal dysfunction and injury
暂无分享,去创建一个
[1] J. Rickman,et al. Guilt and dynamics of psychological disorder. , 1948, Lancet.
[2] I. Estrin,et al. ANALGESIC ABUSE AND THE KIDNEY--A COMMENTARY. , 1964, JAMA.
[3] E. Huskisson,et al. Azotaemia Aggravated by Tetracycline , 1970, British medical journal.
[4] H. Cutting. Inappropriate secretion of antidiuretic hormone secondary to vincristine therapy. , 1971, The American journal of medicine.
[5] J. Block,et al. Antidiuretic response to cyclophosphamide in man. , 1973, The Journal of pharmacology and experimental therapeutics.
[6] G. Eknoyan. Toxic nephropathies. , 1973, Texas medicine.
[7] B. Clayton,et al. A VARIANT OF PHENYLKETONURIA , 1975, The Lancet.
[8] B. Iversen,et al. RETROPERITONEAL FIBROSIS DURING TREATMENT WITH METHYLDOPA , 1975, The Lancet.
[9] C. Ponticelli,et al. Late recovery of renal function in a woman with the hemolytic uremic syndrome. , 1977, Clinical nephrology.
[10] F. Gloor,et al. Changing concepts in pathogenesis and morphology of analgesic nephropathy as seen in Europe. , 1978, Kidney international.
[11] R. Nanra,et al. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. , 1978, Kidney international.
[12] R. Patel,et al. Symptomatic hypomagnesemia associated with gentamicin therapy. , 1979, Nephron.
[13] G. Kaloyanides,et al. Aminoglycoside nephrotoxicity. , 1980, Kidney international.
[14] N. Lichtenstein,et al. Low fractional excretion of sodium with contrast media-induced acute renal failure. , 1980, Archives of internal medicine.
[15] D. Hauglustaine,et al. OESTROGEN CONTAINING ORAL CONTRACEPTIVES, DECREASED PROSTACYCLIN PRODUCTION, AND HAEMOLYTIC URAEMIC SYNDROME , 1981, The Lancet.
[16] S. Johansson,et al. Renal pelvic neoplasms and atypical urothelium in patients with end-stage analgesic nephropathy. , 1981, Kidney international.
[17] A. Magil. Drug-induced acute interstitial nephritis with granulomas. , 1983, Human pathology.
[18] D M Clive,et al. Renal syndromes associated with nonsteroidal antiinflammatory drugs. , 1984, The New England journal of medicine.
[19] M. Rudnick,et al. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy. , 1984, Annals of internal medicine.
[20] A. Murgo,et al. Renal failure and hemolytic anemia associated with mitomycin C. A case report , 1985, Cancer.
[21] B D Kahan,et al. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine. , 1985, Surgery.
[22] P. H. Bach,et al. Relevance of animal models to analgesic-associated renal papillary necrosis in humans , 1985 .
[23] L. Giroux,et al. Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases. , 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] J. Stewart,et al. Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer. , 1986, Kidney international.
[25] D. Kleinknecht,et al. Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients. , 1987, Advances in experimental medicine and biology.
[26] M. Fine,et al. Cholesterol Crystal Embolization: A Review of 221 Cases in the English Literature , 1987, Angiology.
[27] G. Deferrari,et al. Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresis. , 1989, Nephron.
[28] G. Porter. Contrast-associated nephropathy. , 1989, The American journal of cardiology.
[29] V. V. Waters. Hydralazine, hydrochlorothiazide and ampicillin associated with retroperitoneal fibrosis: case report. , 1989, The Journal of urology.
[30] G. Remuzzi,et al. Thrombotic thrombocytopenic purpura and related disorders. , 1990, Hematology/oncology clinics of North America.
[31] W. Kupin,et al. Reversal of cyclosporine-associated hemolytic-uremic syndrome by plasma exchange with fresh-frozen plasma replacement in renal transplant recipients. , 1991, Transplantation proceedings.
[32] P. Vereerstraeten,et al. Induction of thromboses within renal grafts by high-dose prophylactic OKT3 , 1992, The Lancet.
[33] J. Berns,et al. Inherited hemolytic uremic syndrome in adults. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[34] J. Bernheim,et al. Cholesterol embolization syndrome following thrombolytic therapy with streptokinase and tissue plasminogen activator. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[35] T V Perneger,et al. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. , 1994, The New England journal of medicine.
[36] D. Kleinknecht. Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. , 1995, Seminars in nephrology.
[37] F. Keller,et al. Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[38] W. Bennett,et al. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. , 1996, Kidney international.
[39] D. Fliser. Loop diuretics and thiazides--the case for their combination in chronic renal failure. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[40] E. Burdmann,et al. Anuric acute renal failure caused by dextran 40 administration. , 1997, Renal failure.
[41] J. Bosmans,et al. Antibiotic and immunosuppression-related renal failure , 1997 .
[42] A. Teufel,et al. Reinstitution of gold after gold induced proteinuria. , 1997, The Journal of rheumatology.
[43] Use of diuretics in chronic renal failure. , 1997, Kidney international. Supplement.
[44] J. Diamond,et al. Obstructive nephropathy as a result of retroperitoneal fibrosis: a review of its pathogenesis and associations. , 1997, Journal of the American Society of Nephrology : JASN.
[45] Mannitol-induced acute renal failure. , 1997, Journal of the American Society of Nephrology : JASN.
[46] C. Katlama,et al. Indinavir crystal deposits associated with tubulointerstitial nephropathy. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[47] C. Wilcox,et al. Metabolic and adverse effects of diuretics. , 1999, Seminars in nephrology.
[48] P. Baylor,et al. Interstitial nephritis, thrombocytopenia, hepatitis, and elevated serum amylase levels in a patient receiving clarithromycin therapy. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] T. Kameda,et al. Etidronate (EHDP) Inhibits Osteoclastic-Bone Resorption, Promotes Apoptosis and Disrupts Actin Rings in Isolate-Mature Osteoclasts , 1999, Calcified Tissue International.
[50] L. Truong,et al. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. , 1999, Transplantation.
[51] H. Hataya,et al. Renal atrophy associated with long-term treatment with indinavir. , 1999, The New England journal of medicine.
[52] T. Cihlar,et al. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.
[53] V. D’Agati,et al. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. , 2000, Journal of the American Society of Nephrology : JASN.
[54] M. Little,et al. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus , 2000, Transplant international : official journal of the European Society for Organ Transplantation.
[55] S. Chinnakotla,et al. Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient. , 2000, Transplantation.
[56] W Zidek,et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.
[57] N. Ordóñez,et al. Macrophagelike Vacuolated Renal Tubular Cells in the Urine of a Male with Osmotic Nephrosis Associated with Intravenous Immunoglobulin Therapy , 2000, Acta Cytologica.
[58] D. Ellison. Diuretic Therapy and Resistance in Congestive Heart Failure , 2002, Cardiology.
[59] P. Kintzel. Anticancer Drug—Induced Kidney Disorders , 2001, Drug safety.
[60] J. Rossert. Drug-induced acute interstitial nephritis. , 2001, Kidney international.
[61] G. Remuzzi,et al. Drug-Induced Thrombotic Microangiopathy , 2001, Drug safety.
[62] P. Fine,et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. , 2001, Journal of the American Society of Nephrology : JASN.
[63] Pathophysiology of Cyclosporine-Induced Nephrotoxicity in Humans: A Role for Nitric Oxide? , 2001, Kidney and Blood Pressure Research.
[64] A. Serra,et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.
[65] J. George,et al. Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome , 2001, Current opinion in hematology.
[66] D. Glotz,et al. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. , 2001, The American journal of medicine.
[67] W. Bennett,et al. Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies , 2001, Current opinion in critical care.
[68] M. Joerger,et al. Gemcitabine-associated hemolytic-uremic syndrome. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[69] S. Marsch,et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.
[71] Severe electrolyte disturbances and renal failure in elderly patients with combined diuretic therapy including xipamid. , 2002, Wiener klinische Wochenschrift.
[72] H. Skelton,et al. Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors , 2002, The British journal of dermatology.
[73] P. Fine,et al. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). , 2003, Kidney international.
[74] Wu-chang Yang,et al. Tacrolimus-associated hemolytic uremic syndrome: a case analysis. , 2003, Journal of nephrology.
[75] G. Marenzi,et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. , 2003, The New England journal of medicine.
[76] R. Quinet,et al. Celecoxib-related renal papillary necrosis. , 2003, Archives of internal medicine.
[77] F. S. Pereles,et al. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. , 2003, Journal of vascular surgery.
[78] P. O'kelly,et al. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[79] J. Bonventre,et al. Biologic markers for the early detection of acute kidney injury , 2004, Current opinion in critical care.
[80] R. Klein,et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[81] M. Daudon,et al. Drug-induced renal calculi: epidemiology, prevention and management. , 2004, Drugs.
[82] S. Tobe,et al. Acute Interstitial Nephritis Due to Pantoprazole , 2004, The Annals of pharmacotherapy.
[83] J. Chapman,et al. ORAL CYCLOSPORINE BUT NOT TACROLIMUS REDUCES RENAL TRANSPLANT BLOOD FLOW , 2004, Transplantation.
[84] Y. Shoenfeld,et al. Intravenous immunoglobulin and the kidney--a two-edged sword. , 2004, Seminars in arthritis and rheumatism.
[85] J. Pochet,et al. Telithromycin-induced acute interstitial nephritis: a first case report. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[86] K. Bhojani,et al. NSAIDs and kidney. , 2004, The Journal of the Association of Physicians of India.
[87] Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. , 2004, The New England journal of medicine.
[88] Quiz page. Tubular epithelial injury consistent with osmotic nephrosis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[89] A. Cunningham,et al. Fenoldopam Mesylate for the Prevention of Contrast-Induced Nephropathy: A Randomized Controlled Trial , 2004 .
[90] J. Cruz,et al. Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. , 2004, Journal of neurosurgery.
[91] M. Takano,et al. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. , 2004, Drug metabolism and pharmacokinetics.
[92] Hemofiltration and the prevention of radiocontrast-agent-induced nephropathy. , 2004, The New England journal of medicine.
[93] D. Mevorach,et al. Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature. , 2004, Arthritis and rheumatism.
[94] J. Buturović,et al. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy. , 2005, Transplantation proceedings.
[95] New pharmacological protocols to prevent or reduce contrast media nephropathy. , 2005, Minerva cardioangiologica.
[96] J. Frøkiaer,et al. Altered expression of selected genes in kidney of rats with lithium-induced NDI. , 2005, American journal of physiology. Renal physiology.
[97] T. Uehara,et al. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats , 2005, Archives of Toxicology.
[98] C. Bennett,et al. Drug-Induced Thrombotic Microangiopathy , 2005, Seminars in thrombosis and hemostasis.
[99] Hassane Izzedine,et al. Antiviral drug-induced nephrotoxicity. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[100] John Anderson,et al. Cholesterol Emboli-induced Renal Failure and Gastric Ulcer After Thrombolytic Therapy , 2005, Southern medical journal.
[101] L. Damstrup,et al. Retroperitoneal fibrosis after long-term daily use of ergotamine , 2005, International Urology and Nephrology.
[102] W. Henrich. Nephrotoxicity of several newer agents. , 2005, Kidney international. Supplement.
[103] N. Lameire. The pathophysiology of acute renal failure. , 2005, Critical care clinics.
[104] M. Razzaque,et al. Cisplatin-associated nephrotoxicity and pathological events. , 2005, Contributions to nephrology.
[105] John R Perfect,et al. Liposomal amphotericin B: clinical experience and perspectives , 2005, Expert review of anti-infective therapy.